AU2002216503A1 - Ionophore antibiotic formulations - Google Patents

Ionophore antibiotic formulations

Info

Publication number
AU2002216503A1
AU2002216503A1 AU2002216503A AU2002216503A AU2002216503A1 AU 2002216503 A1 AU2002216503 A1 AU 2002216503A1 AU 2002216503 A AU2002216503 A AU 2002216503A AU 2002216503 A AU2002216503 A AU 2002216503A AU 2002216503 A1 AU2002216503 A1 AU 2002216503A1
Authority
AU
Australia
Prior art keywords
antibiotic formulations
ionophore antibiotic
ionophore
formulations
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002216503A
Other versions
AU2002216503B2 (en
AU2002216503B9 (en
Inventor
Kim Ewing Melville Agnew
Craig Richard Hanham
William Austin Hewitt
Kevin Grant Purdy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco US Inc
Original Assignee
Elanco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ509092A external-priority patent/NZ509092A/en
Application filed by Elanco US Inc filed Critical Elanco US Inc
Priority claimed from PCT/NZ2001/000290 external-priority patent/WO2002049609A1/en
Publication of AU2002216503A1 publication Critical patent/AU2002216503A1/en
Publication of AU2002216503B2 publication Critical patent/AU2002216503B2/en
Application granted granted Critical
Publication of AU2002216503B9 publication Critical patent/AU2002216503B9/en
Assigned to Elanco U.S. Inc. reassignment Elanco U.S. Inc. Request for Assignment Assignors: ELI LILLY & COMPANY (NZ) LIMITED
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002216503A 2000-12-19 2001-12-18 Ionophore antibiotic formulations Expired AU2002216503B9 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NZ509092 2000-12-19
NZ509092A NZ509092A (en) 2000-12-19 2000-12-19 Ionophore antibiotic formulations containing a dispersing agent with the ionophore antibiotic having a mean particle size of less than 20 microns
NZ514183 2001-09-13
NZ51418301 2001-09-13
PCT/NZ2001/000290 WO2002049609A1 (en) 2000-12-19 2001-12-18 Ionophore antibiotic formulations

Publications (3)

Publication Number Publication Date
AU2002216503A1 true AU2002216503A1 (en) 2002-09-05
AU2002216503B2 AU2002216503B2 (en) 2006-04-27
AU2002216503B9 AU2002216503B9 (en) 2006-10-12

Family

ID=26652236

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1650302A Pending AU1650302A (en) 2000-12-19 2001-12-18 Ionophore antibiotic formulations
AU2002216503A Expired AU2002216503B9 (en) 2000-12-19 2001-12-18 Ionophore antibiotic formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU1650302A Pending AU1650302A (en) 2000-12-19 2001-12-18 Ionophore antibiotic formulations

Country Status (12)

Country Link
US (2) US20040071782A1 (en)
EP (1) EP1345587B1 (en)
KR (1) KR20030078871A (en)
AR (1) AR031939A1 (en)
AT (1) ATE440591T1 (en)
AU (2) AU1650302A (en)
BR (1) BRPI0116282B1 (en)
CA (1) CA2430791C (en)
DE (1) DE60139712D1 (en)
ES (1) ES2331406T3 (en)
MX (1) MXPA03005512A (en)
WO (1) WO2002049609A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910323A1 (en) * 2006-12-26 2008-06-27 Virbac Sa Sa Liquid anhydrous composition, useful e.g. to prepare oral medications that are diluted with drinking water to prevent/treat diseases of livestock, comprises active ingredient dissolved in organic solvents, surfactant and xanthan gum
US9149456B2 (en) * 2008-07-28 2015-10-06 Zoetis Services Llc Laidlomycin compositions and methods
US8415121B2 (en) * 2009-10-05 2013-04-09 Alpharma, Llc Process for the manufacture of laidlomycin
HUE062147T2 (en) 2015-02-17 2023-10-28 Univ Gent Solid pharmaceutical dosage form suitable for use as drinking water medication
CN107530286B (en) * 2015-04-28 2021-11-16 伊兰科美国公司 Monensin water dispersible granules using wet granulation
KR102227147B1 (en) * 2018-08-30 2021-03-12 한국화학연구원 Adjuvant for preventing or treating of viral diseases comprising ionophore as an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754856A (en) 1969-08-18 1971-02-15 Hoffmann La Roche NEW ANTIBIOTICS
US3829557A (en) 1970-06-12 1974-08-13 Erco Ind Ltd Production of chlorine dioxide
US3839557A (en) * 1972-01-24 1974-10-01 Lilly Co Eli Antibiotics monensin and a204 for improving ruminant feed efficiency
IL70015A0 (en) 1983-10-20 1984-01-31 Koffolk 1949 Ltd Ionophore antibiotic compositions and processes for the preparation thereof
US4746349A (en) * 1986-08-06 1988-05-24 American Cyanamid Company Method and compositions for suppressing the nitrification of ammonium in plant growth medium
ATE264667T1 (en) * 1995-07-14 2004-05-15 Elli Lilly & Co Nz Ltd FORMULATIONS WITH MONENSIN
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
DE69620478T2 (en) * 1996-10-17 2002-11-21 Eli Lilly And Co., Indianapolis METHOD FOR PRESERVING ANIMAL SKINS
US6086633A (en) * 1996-10-17 2000-07-11 Eli Lilly And Company Method for preserving animal hides
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
AUPR034000A0 (en) Aminoalcohol derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001295657A1 (en) Formulation containing wax-esters
AU2000267458A1 (en) Hypercomputer
AU2001272719A1 (en) Macrolide antibiotics
AU2001230537A1 (en) Pyridoxazine derivatives
AUPQ441699A0 (en) Pour-on formulations
AUPQ585000A0 (en) Aminoalcohol derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001278694A1 (en) Avermectin derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001232092A1 (en) Amplifier
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2002216503A1 (en) Ionophore antibiotic formulations
AU1650302A (en) Ionophore antibiotic formulations
AU2002230386A1 (en) Sixteen-membered macrolide compounds